MarketInOut Stock Screener Log In | Sign Up
 

CellBxHealth Plc

LSE • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
CellBxHealth Plc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeLSE
Market Capitalization7.67 mln
Float1,057 mln
Earnings Date04/29/2027

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-9.41
Highly reliable

1-Year Forecast

3.00
Transformational upside

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.32
Low leverage

Pre-Tax Margin

-1,169%
Severely loss-making

Business Description

CelLBxHealth plc is a UK-based medical diagnostics company focused on detecting and analyzing cancer cells found circulating in patients' blood. Its core products include devices and laboratory kits that capture these cells from blood samples, helping clinicians better understand and characterize cancers such as metastatic breast cancer. The company also offers a range of laboratory testing services and works alongside partners including BioView Ltd, NuProbe USA, and The Royal Marsden NHS Foundation Trust to advance its diagnostic capabilities. Founded in 1994 and headquartered in Guildford, it operates across Europe, North America, and other international markets.

Key Fundamentals

EPS-3.00
ROE-169
RPS0.00
ROIC-221
ROA-101
EBITDA, mln-10.02
EV / EBITDA-0.89
EV / EBIT-0.67
Revenue, mln1.15
EV / Revenue7.77

Quote Details

Last 0.625
Change -0.023 (-3.55%)
Open 0.5677
Volume 2,211,906
Turnover 1,382,441
Average Volume 2,786,292

Financial Ratios

Pre-Tax Profit Margin-1,169
Current Ratio2.54
Price / Book2.19
Debt / Equity0.32
Price / Sales4.38

Financial Strength

Altman Z-Score-20.29
Piotroski F-Score 2 / 9
Beneish M-Score-9.41
1-Year Target Price3.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -22.36% 1 / 100   
1 Month -24.33% 3 / 100   
2 Months -51.92% 1 / 100   
6 Months -32.07% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog